As of June 2026, 1 paid clinical trial is recruiting for Metastatic breast cancer in Dearborn, Michigan. Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Dearborn has approximately 84 recruiting research studies across a wide range of therapeutic areas. Michigan hosts University of Michigan Health, Henry Ford Health, and Corewell Health, running trials across oncology, neurology, and cardiology with a strong focus on precision medicine.
Researchers run research studies in Dearborn, MI at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Henry Ford Medical Center-Fairlane | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Chronic Lymphocytic Leukemia | 38 |
| Corewell Health Dearborn Hospital | Breast Cancer, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 28 |
| Revival Research Institute, LLC | Atherosclerotic Cardiovascular Disease (ASCVD), COPD, COVID-19 SARS-CoV-2 Infection | 7 |
| AMR Dearborn | Heart Failure | 1 |
| Advanced Surgery Center | Lumbar Spinal Stenosis | 1 |
| Center for Neurolgoical Studies (CNS) | Anterior Pituitary Hyposecretion Syndrome, Concussion, Brain, Growth Hormone Deficiency | 1 |
| Corazon Imaging | Atherosclerosis, Cardiovascular Inflammation, Coronary Artery Disease | 1 |
| Dearborn Cardiology | Chronic Total Occlusion of Artery of the Extremities | 1 |
| Dearborn Surgery Center | Lumbar Spinal Stenosis | 1 |
| Executive Ambulatory Surgical Center | Lumbar Spinal Stenosis | 1 |
| Henry Ford Health System | Community-acquired Pneumonia | 1 |
| Henry Ford Health System - Dearborn | Lumbar Spinal Stenosis | 1 |
| Insight Research Institute, Dearborn | AChR Myasthenia Gravis, Generalized Myasthenia, MuSK MG | 1 |
| Metro Detroit Endocrinology Center | Hypothyroidism | 1 |
| Michigan Hematology & Oncology Consultants - Dearborn | Plasma Cell Myeloma Refractory | 1 |
| Michigan Hematology & Oncology Consultants - MedOnc Dearborn | Colorectal Cancer, Melanoma, Non-small Cell Lung Cancer | 1 |
| Michigan Hematology and Oncology Consultants | Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer | 1 |
| Profound Research LLC/Michigan Hematology & Oncology Consultants | HER2-positive Advanced Solid Tumor | 1 |
| Profound Research, LLC | Influenza | 1 |
| Revival Research Institute, LLC - Dearborn | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| WSUPG Dermatology | Hidradenitis Suppurativa | 1 |
Recruiting trials in Dearborn grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Michigan are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Michigan research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Dearborn from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 84 recruiting clinical trials in Dearborn, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Dearborn compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Dearborn include Anatomic Stage II Breast Cancer AJCC v8 (4), Breast Cancer (4), Malignant Solid Neoplasm (4), Clinical Stage III Esophageal Adenocarcinoma AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Dearborn on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Dearborn include Henry Ford Medical Center-Fairlane, Corewell Health Dearborn Hospital, Revival Research Institute, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Dearborn are Cancer & tumors (55), Cardiovascular (6), Vaccines (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.